Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors.

[1]  L. Horner,et al.  Die Synthese brückenanaloger Thyroninverbindungen , 1952 .

[2]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[3]  H. Brodaty,et al.  THA and Alzheimer's disease. , 1987, The Australian and New Zealand journal of psychiatry.

[4]  Galanthamine treatment in Alzheimer's disease. , 1991, Journal of neural transmission. Supplementum.

[5]  H. Sugimoto,et al.  Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. , 1995, Journal of medicinal chemistry.

[6]  N. Inestrosa,et al.  Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides , 1995, Neuroscience Letters.

[7]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[8]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[9]  L. Kelley,et al.  An automated approach for defining core atoms and domains in an ensemble of NMR-derived protein structures. , 1997, Protein engineering.

[10]  Joel L. Sussman,et al.  Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica , 1998, Journal of Physiology-Paris.

[11]  C. Spencer,et al.  Rivastigmine. A review of its use in Alzheimer's disease. , 1998, Drugs & aging.

[12]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[13]  D. Learmonth.  RAPID MICROWAVE-PROMOTED SYNTHESIS OF FUNCTIONALISED BENZOPHENONES , 2002 .

[14]  V. Andrisano,et al.  beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. , 2003, Biochemical pharmacology.

[15]  A. Cavalli,et al.  3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy. , 2003, Journal of medicinal chemistry.

[16]  Andrea Cavalli,et al.  A Comparative Study on the Application of Hierarchical-Agglomerative Clustering Approaches to Organize Outputs of Reiterated Docking Runs , 2006, J. Chem. Inf. Model..

[17]  V. Andrisano,et al.  Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones. , 2007, Bioorganic & medicinal chemistry.